Semax – 10mg

Semax is a synthetic seven-residue peptide developed by Russian researchers, an analogue of an ACTH fragment extended with a proline-glycine-proline tail that resists enzymatic cleavage. Supplied lyophilised, 10mg per vial at $4.50 per mg. It is unrelated to the similarly-spelled GLP-1 compound: under the WHO naming system a drug's class sits in its suffix, so a shared prefix carries no information. Six coupling steps make this a short, reliable synthesis, which shifts verification away from hunting trace impurities and toward confirming identity by mass spectrometry, confirming the sequence explicitly rather than the name, and checking fill weight separately. Much of the primary literature is Russian-language and hard to assess second-hand. Research use only.

Transparency

Certificate of Analysis

Every batch independently verified by third-party laboratories.

PASS

Semax – 10mg COA

Independently tested

Live

Purity≥99.4%

MethodHPLC

Documents1 PDF

View COA COA Library

All Proxiva Peptides products are independently tested by accredited third-party laboratories. Results are batch-specific and provided for research transparency only. This product is not approved for human use.

Lab Verified

Every Dose, Independently Tested

Verified by Vanguard Laboratory — always ≥99.5% purity, tested 7×.